J.W. Cole Advisors, Inc. Exact Sciences Corp Transaction History
J.W. Cole Advisors, Inc.
- $3.14 Billion
- Q1 2025
A detailed history of J.W. Cole Advisors, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 9,716 shares of EXAS stock, worth $545,844. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,716
Previous 8,582
13.21%
Holding current value
$545,844
Previous $482,000
12.86%
% of portfolio
0.01%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding EXAS
# of Institutions
645Shares Held
157MCall Options Held
1.74MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA17.8MShares$1 Billion0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$991 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$702 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$678 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$372 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.94B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...